These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38840915)

  • 21. CD209/CD14
    Marzaioli V; Canavan M; Floudas A; Flynn K; Mullan R; Veale DJ; Fearon U
    Front Immunol; 2021; 12():722349. PubMed ID: 35095831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication.
    Gargaro M; Scalisi G; Manni G; Briseño CG; Bagadia P; Durai V; Theisen DJ; Kim S; Castelli M; Xu CA; Meyer Zu Hörste G; Servillo G; Della Fazia MA; Mencarelli G; Ricciuti D; Padiglioni E; Giacchè N; Colliva C; Pellicciari R; Calvitti M; Zelante T; Fuchs D; Orabona C; Boon L; Bessede A; Colonna M; Puccetti P; Murphy TL; Murphy KM; Fallarino F
    Immunity; 2022 Jun; 55(6):1032-1050.e14. PubMed ID: 35704993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.
    Amoruso A; Sola D; Rossi L; Obeng JA; Fresu LG; Sainaghi PP; Pirisi M; Brunelleschi S
    Pharmacol Res; 2016 May; 107():308-314. PubMed ID: 27045818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.
    Schulz S; Landi A; Garg R; Wilson JA; van Drunen Littel-van den Hurk S
    Clin Exp Immunol; 2015 Jun; 180(3):484-98. PubMed ID: 25605587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate Treatment of Newly Diagnosed RA Patients Is Associated With DNA Methylation Differences at Genes Relevant for Disease Pathogenesis and Pharmacological Action.
    Guderud K; Sunde LH; Flåm ST; Mæhlen MT; Mjaavatten MD; Norli ES; Evenrød IM; Andreassen BK; Franzenburg S; Franke A; Rayner S; Gervin K; Lie BA
    Front Immunol; 2021; 12():713611. PubMed ID: 34867944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis.
    de Rotte MC; de Jong PH; den Boer E; Pluijm SM; Özcan B; Weel AE; Lindemans J; Hazes JM; de Jonge R
    Arthritis Rheumatol; 2014 Aug; 66(8):2026-36. PubMed ID: 24692301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.
    Ellingsen T; Hansen I; Thorsen J; Kuno Møller B; Tarp U; Jacobsen S; Lund Hetland M; Vestergaard A; Hørslev-Petersen K; Stengaard-Pedersen K
    Clin Exp Rheumatol; 2012; 30(1):58-63. PubMed ID: 22273590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
    Nguyen THP; Hokstad I; Fagerland MW; Mollnes TE; Hollan I; Feinberg MW; Hjeltnes G; Eilertsen GØ; Mikkelsen K; Agewall S
    PLoS One; 2022; 17(2):e0264628. PubMed ID: 35213675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
    Palmowski A; Strehl C; Pfeiffenberger M; Häupl T; Schad M; Kallarackal J; Prothmann U; Dammann D; Bonin M; Brandt A; Schneider U; Gaber T; Buttgereit F
    Clin Rheumatol; 2024 Jan; 43(1):511-519. PubMed ID: 37978145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.
    Trabanelli S; Očadlíková D; Ciciarello M; Salvestrini V; Lecciso M; Jandus C; Metz R; Evangelisti C; Laury-Kleintop L; Romero P; Prendergast GC; Curti A; Lemoli RM
    J Immunol; 2014 Feb; 192(3):1231-40. PubMed ID: 24391212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression patterns of CD28 and CTLA-4 in early, chronic, and untreated rheumatoid arthritis.
    García-Chagollán M; Ledezma-Lozano IY; Hernández-Bello J; Sánchez-Hernández PE; Gutiérrez-Ureña SR; Muñoz-Valle JF
    J Clin Lab Anal; 2020 May; 34(5):e23188. PubMed ID: 31907973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
    Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
    Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloid-related Protein 8/14 Levels in Rheumatoid Arthritis: Marker of Disease Activity and Response to Methotrexate.
    Patro PS; Singh A; Misra R; Aggarwal A
    J Rheumatol; 2016 Apr; 43(4):731-7. PubMed ID: 26834220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased IgG4 ACPA levels in responders and increased CD1c
    Engelmann R; Nekarda S; Kuthning D; Kneitz C; Müller-Hilke B
    Clin Rheumatol; 2018 Jul; 37(7):1783-1790. PubMed ID: 29502227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.
    Emery P; Burmester GR; Bykerk VP; Combe BG; Furst DE; Barré E; Karyekar CS; Wong DA; Huizinga TW
    Ann Rheum Dis; 2015 Jan; 74(1):19-26. PubMed ID: 25367713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity.
    Toussirot E; Saas P; Deschamps M; Pouthier F; Perrot L; Perruche S; Chabod J; Tiberghien P; Wendling D
    Arthritis Res Ther; 2009; 11(4):R101. PubMed ID: 19570209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide.
    Zhong W; Zhao L; Liu T; Jiang Z
    Sci Rep; 2017 Jan; 7():41143. PubMed ID: 28117352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDR-1 and MRP-1 activity in peripheral blood leukocytes of rheumatoid arthritis patients.
    Micsik T; Lőrincz A; Gál J; Schwab R; Peták I
    Diagn Pathol; 2015 Dec; 10():216. PubMed ID: 26715450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
    Sellam J; Rouanet S; Hendel-Chavez H; Abbed K; Sibilia J; Tebib J; Le Loët X; Combe B; Dougados M; Mariette X; Taoufik Y
    Arthritis Rheum; 2011 Dec; 63(12):3692-701. PubMed ID: 22127692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.